HealthVerity Notes: The hidden goldmine in healthcare data
HealthVerity recently introduced HealthVerity Notes, our newest product designed to unlock the...
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world...
HealthVerity recently introduced HealthVerity Notes, our newest product designed to unlock the...
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not...
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
Why data provenance matters for regulatory submissions and clinical trials Regulators increasingly...
This is part three of a three-part series on the essential qualities of claims data for life...
Understanding PBC and today’s treatment landscape Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease marked by immune-mediated damage to the small bile ducts inside the liver. Over time, that injury can lead to cholestasis (reduc...